Introduction
============

*Wolbachia* is the most widespread endosymbiotic bacterium of insects and other arthropods ([@bib53]). It is vertically transmitted from mother to offspring. It also often exhibits effects on host reproductive biology allowing rapid invasion of host populations (cf, [@bib43]). One such reproductive manipulation is cytoplasmic incompatibility (CI), manifested as death of embryos produced by a fusion of *Wolbachia*-infected sperm with uninfected eggs or eggs that carry an incompatible *Wolbachia* infection ([@bib52]). This mechanism gives a reproductive advantage to *Wolbachia-*infected females whose eggs are protected from CI, driving the *Wolbachia* invasion through host populations ([@bib17]).

Because *Wolbachia* infection also confers increased host resistance to many pathogens, it is considered as a novel biocontrol method for suppressing vector-borne human diseases such as dengue ([@bib34]). The main vector of dengue, the *Aedes aegypti* mosquito, does not carry *Wolbachia* infections in the wild ([@bib24]), but there are now several *Wolbachia*-infected *A. aegypti* strains created by laboratory transfection from other insect hosts ([@bib31]; [@bib47]). *Wolbachia* infections originating from *Drosophila melanogaster* (*w*Mel and *w*MelPop) and *Aedes albopictus* (*w*AlbB) reduce dengue virus load significantly in *A. aegypti* ([@bib3]; [@bib34]; [@bib47]). In addition, a strain like *w*MelPop can reduce the adult lifespan and viability of quiescent eggs in *A. aegypti* ([@bib31]; [@bib33]; [@bib51]). Life-shortening and virus interference effects in the mosquito host are expected to decrease dengue incidence, given that older mosquitoes are more likely to transmit diseases to humans (cf, [@bib9]).

*Wolbachia*-based strategies for disease suppression rely on the release of mosquitoes with a particular *Wolbachia* infection into the field. The *Wolbachia* then invades and replaces the resident population with mosquitoes that have a reduced potential for disease transmission ([@bib15]). The successful introduction of *Wolbachia* into natural mosquito populations requires the release of high-quality material that can invade the population and persist over time. Such release material should contain a *Wolbachia* infection that induces very strong CI, (near) perfect maternal transmission (that is, very weak maternal transmission leakage) and a small fitness cost to the host ([@bib16]).

The quality of release material can be assessed in several ways: (1) via laboratory fitness tests (see, for example, [@bib32]; [@bib15]; [@bib51]; [@bib39]; [@bib46]), (2) through the monitoring of performance during trial releases ([@bib50]) as well as (3) by tracking the changes in *Wolbachia* infection frequency over time ([@bib15]; [@bib14]). The latter can indicate the stability of the infection under possible imperfect maternal transmission and/or immigration of uninfected individuals.

A different approach for tracking the dynamics of *Wolbachia* in invaded populations is to examine mitochondrial DNA (mtDNA) variants associated with the infection. Because both *Wolbachia* and mitochondria are maternally inherited, the mitochondrial genome will be in linkage disequilibrium with the endosymbiont ([Figure 1](#fig1){ref-type="fig"}, upper). The level of disequilibrium between the two genomes depends on the fidelity of maternal transmission and incidence of paternal transmission ([@bib45]; [@bib21]). Linkage disequilibrium between *Wolbachia* and mtDNA variation was first reported in *Drosophila simulans* ([@bib10]), following the spread of the *Riverside* infection (*w*Ri) in California ([@bib43]; [@bib44]). Such co-occurrence of mtDNA and *Wolbachia* infection has been detected subsequently in other species (see, for example, [@bib1]; [@bib40]).

As a consequence of CI and maternal co-transmission of *Wolbachia* and mtDNA, an isolated population invaded by *Wolbachia* would be likely to contain only the mitochondrial background associated with the infection, regardless of the *Wolbachia* maternal transmission rates ([@bib45]). In *A. aegypti*, *Wolbachia* induces very strong CI (\>99.9%) ([@bib31]; [@bib47]; [@bib51]) and all transfected mosquitoes should share a common mitochondrion as they are descendants of a single female ([@bib31]; [@bib47]). This association provides an opportunity to study *Wolbachia* dynamics following the invasion of the *A. aegypti* field populations, as long as the local and release mosquitoes have divergent mitochondrial genomes. In particular, deviations from perfect *Wolbachia* transmission should generate uninfected mosquitoes with a mitochondrial background associated with the infection, whereas immigration of uninfected mosquitoes should lead to the occurrence/maintenance of uninfected mosquitoes with a background different from the infected mosquitoes.

Here, our first aim was to (1) provide a set of diagnostic mitochondrial molecular markers for tracking the *Wolbachia* dynamics in populations of the dengue fever mosquito *A. aegypti*, given the recent field releases of *Wolbachia*-infected mosquitoes in Australia, Vietnam, Indonesia and Brazil to supress dengue transmission. Furthermore, we aimed to (2) develop a model framework for the *Wolbachia* infection and haplotype counts. We define a null model with the assumptions of perfect maternal co-transmission of mitochondria and *Wolbachia*, complete CI and isolation of an invaded field population. Deviations from null expectations are then explored and used to generate hypothetical scenarios for transmission parameters based on known studies of *A. aegypti* invasion with approximated fitness and population parameters. We also apply our framework to elucidate parameters of a documented *Wolbachia* invasion in *Drosophila*. Finally, we discuss applications (such as sampling strategies) and challenges in using mitochondrial variation as a monitoring tool for understanding *Wolbachia* dynamics in host populations.

Materials and methods
=====================

Development of diagnostic mitochondrial molecular markers in *A. aegypti*
-------------------------------------------------------------------------

### Samples

To obtain diagnostic markers that differentiate mitochondrial haplotypes associated with the *Wolbachia* infection from haplotypes of uninfected individuals, mtDNA variation was analysed in *A. aegypti* individuals from different sources. (1) From laboratory colonies with three different *Wolbachia* transfections: *w*Mel and *w*MelPop (originating from *D. melanogaster*; [@bib30]; [@bib47]) and *w*AlbB (originating from *A. albopictus*; [@bib48]). (2) From uninfected mosquitoes originating from field populations in Australia, Indonesia, Vietnam and Brazil. In total, we analysed amplicon sequence data in 82 individuals from the *Wolbachia*-infected colonies and 227 uninfected individuals from the field, and double-digest restriction associated DNA (ddRAD) sequences in 257 individuals from the field (including the *w*Mel infected). Sample sizes and dates for each collection are summarised in [Table 1](#tbl1){ref-type="table"}.

Samples were screened for single-nucleotide polymorphisms (SNPs) in several regions of the *A. aegypti* mitochondrial genome using amplicon sequencing and ddRAD sequencing (ddRAD-seq). As the ddRAD sequences span a wider region, they could reveal additional variation to separate infected versus uninfected individuals.

### Amplicon sequencing

We screened regions of three mitochondrial genes: (1) *cyt* b gene (307 bp; [@bib35]), (2) *ND*5 gene (\~450 bp; [@bib35]) and (3) *COI* gene ([@bib28]). ([Table 1](#tbl1){ref-type="table"}). Details of primer sequences and reaction conditions are found in [Supplementary Tables S1 and S2](#sup1){ref-type="supplementary-material"}.

PCR amplicons were sequenced from both directions using Sanger sequencing (Macrogen Inc., Geumcheongu, Seoul, South Korea) and the chromatograms were analysed using Geneious version 6.1.5 (<http://www.geneious.com>, [@bib23]). The identity of amplicons was confirmed with the BLASTn sequence homology searches against the National Center for Biotechnology Information (NCBI) nonredundant nucleotide database.

Samples from Australia and overseas (*n*=223) were also screened at five additional mitochondrial regions: *ND*4 region ([@bib6]) and four mitochondrial regions (amplified by primer pairs 1, 4, 6 and 16) that amplified 900--1200 bp fragments across the mitochondrial genome ([@bib2]) ([Table 1](#tbl1){ref-type="table"} and [Supplementary Tables S1 and S2](#sup1){ref-type="supplementary-material"}).

### The ddRAD-seq

Nucleotide variation in the mitochondrial genome was also screened in 257 individuals using the 100 bp paired-end Illumina sequencing (Randwick, NSW, Australia) of ddRAD-seq. Customised ddRAD libraries were constructed following the protocol described by [@bib38]. In brief, 100 ng of DNA from each individual was digested with the restriction enzymes *NlaIII* and *MluCI* (NEB, Ipswich, MA, USA), and ligated to the Illumina P1 and P2 adapters with customised barcode sequences ([@bib38]). After sample pooling and purification, size selection of fragments from 300 to 450 bp was completed with the Pippin Prep (Sage Sciences, Beverly, MA, USA) protocol. The final library was enriched using 12 PCR cycles with standard Illumina primers.

Raw Illumina sequences were filtered and trimmed to the length of 80 bp using FASTX-Toolkit (<http://hannonlab.cshl.edu/fastx_toolkit/index.html>; key: citeulike: 9103573). The majority of the ddRAD reads in these libraries represented nuclear sequences ([@bib38], and unpublished data), but these were not central to the current work where inferences were based only on mtDNA patterns. Therefore, we retained only reads that were uniquely aligned to the mitochondrial reference genome of *A. aegypti* (Genbank identifier: 164523399) ([@bib2]) by the short read aligner Bowtie ([@bib26]). Variant and likelihood-based genotype calling was done on loci with a depth of at least five reads using the default parameters of the *Stacks* pipeline ([@bib4]).

### Sequence analyses

All coding sequences were first checked for the presence of premature stop codons using Geneious version 6.1.5 (<http://www.geneious.com>, [@bib23]). Haplotype networks were generated in HapStar-0.7 written in Python ([@bib41]). HapStar generates the network graph as a minimum spanning tree between all haplotypes, that is, computing the lowest total Hamming distance (number of mismatches) between all haplotypes. All pairwise Hamming distances between haplotypes were generated using a custom Python 2.7 script. Missing nucleotides in the ddRAD data set were excluded from the distance calculation. Given that HapStar does not account for missing haplotype nodes, we also generated the network graph using TCS ([@bib5]). We considered sequences to be potentially heteroplasmic if their chromatograms contained double peaks (50--100% height) that were present in both sequencing directions, and/or if they were heterozygous in the ddRAD analysis. The potential heteroplasmic sequences were excluded from the haplotype tree reconstruction.

*Wolbachia* dynamics modelling
------------------------------

We were interested in identifying haplotype frequency profiles in infected and uninfected populations under a combination of suboptimal *Wolbachia* transmission effects, such as maternal leakage and presence of immigration/emigration from neighbouring populations. We were particularly interested in two distinct *Wolbachia* invasion fates, namely (1) a *Wolbachia* infection persisting in a population and (2) a *Wolbachia* infection that fails to invade and is lost from a population.

We adapted the overlapping generation model of [@bib42] to incorporate maternal transmission leakage, emigration/immigration and paternal transmission of *Wolbachia.* We did not incorporate rare paternal transmission of mitochondria for which the mode of inheritance would probably be dependent on the assortment of a high density of maternally derived mtDNA and a very low density of paternally derived mtDNA.

### Modelling the *Wolbachia* infection counts

Using the nomenclature of [@bib42], we denoted *I*nfected and *U*ninfected mosquitoes as *I* and *U*, with the number of adult (A) infected and uninfected reproductive females at day *t* as *I*~A,*t*~ and *U*~A,*t*~; and the number of *e*mbryonic (E) females produced at day *t* as *I*~E,*t*~ and *U*~E,*t*~ (see [Table 2](#tbl2){ref-type="table"} for a list of symbols). Similarly, we used an average length of pre-reproductive period, *τ*, with *τ*+1 as the period before a given female starts to reproduce. We assumed that both infected and uninfected individuals spent similar amount of time as pre-reproductives, that is, *τ*~I~=*τ*~U~. We also defined *b*~*I*~ and *b*~*U*~ as the number of female embryos produced per day by an infected and uninfected female respectively. The parameters determining *Wolbachia* dynamics are *μ* (the probability of an infected female not transmitting the infection to the eggs), *H* (the hatch rate of uninfected eggs fertilised by sperm from infected males) and *ξ* (the probability of *Wolbachia* transmission from infected males). For any given time, *t*, the number of pre-reproductive infected and uninfected females (*I*~*E*,*t*~ and *U*~*E*,*t*~) can be expressed as:

The part of the equation multiplied by *I*~A,*t*~ denotes the number of offspring from an infected female, whereas the part multiplied by *U*~A,*t*~ denotes the number of offspring from an uninfected female (see [Table 2](#tbl2){ref-type="table"} for definitions and symbols and [Table 3](#tbl3){ref-type="table"} for derivation).

To account for fitness differences in egg viability in infected and uninfected individuals, we set the average probabilities of an infected and uninfected egg surviving to the larval stage as *δ*~I~ and *δ*~U~ respectively, and average probabilities of infected and uninfected larvae surviving to sexually mature adults, irrespective of larvae competition, as *s*~I~ and *s*~U~ respectively. Then, the number of reproductive infected and uninfected females at time *t*+1, given *τ* days to develop into reproductive adults without larval competition and immigration, can be expressed as:

The number of resultant reproductive adults is also dependent on the survival of reproductive adults from the previous day (*ν*).

To incorporate larval competition with density-dependent larval mortality, we partitioned the life stages to egg, larval and post-larval pre-reproductives. Egg and post-larval pre-reproductives (average duration *ω* and κ days respectively) were considered as not being in competition for resources with larval stages. Eggs laid on day *t*--τ would have hatched on day *t*--τ+*ω*, and larvae on that day would have encountered larvae that were laid as eggs as far back as τ--κ+1 days previously, that is, on day *t*--2τ+*ω*+κ+1. Thus, the average number of larvae encountered per day by larvae that were laid as eggs on day *t*--τ (here denoted as *L*) was the sum of pre-reproductives from *t*--2τ+*ω*+κ+1 to *t--κ* divided by days spent as larvae (that is, τ--*ω*--κ):

Following previous studies ([@bib11]), we used an exponential decay function dependent on the average number of larvae encountered per day by eggs laid on *t*--τ day:

where *a* and *c* are larval density-dependent constants. The superscripts '\*\*\' are referenced below.

### Migration modelling

For emigration/immigration, we considered a simple scenario where only two populations interact, and assumed the same dispersal rate for both infected and uninfected individuals. We also assumed that only reproductive adult females are capable of emigrating/immigrating. We let *I*~A,t~(1), *U*~A,t~(1), *I*~A,t~(2) and *U*~A,t~(2) denote the number of infected and uninfected adults at time *t* in populations 1 and 2, respectively, and *m* represents the emigration/immigration rate per generation between the two populations. Then, the number of infected and uninfected adults at time *t+1* in populations 1 and 2 can be expressed as:

The value of *m* was divided by *τ* (assumed to be the average generation time) to indicate a daily migration rate.

### Modelling the mitochondrial haplotype counts

We designated two mitochondrial haplotypes: *α*, the haplotype prevalent in uninfected individuals, and *β*, the haplotype prevalent in infected individuals. We assume that the two haplotypes are strictly neutral variants. We let *α*~I*,t*~ and *β*~I*,t*~ be the proportion of *I*nfected individuals at time *t* with haplotype *α* and *β* respectively. Similarly, we define *α*~U,*t*~ and *β*~U,*t*~ as equivalent proportions for the *U*ninfected individuals. We let *I*~α,*t*+1~ and *I*~β,*t*+1~ be the number of *I*nfected adult females with haplotype *α* or *β* at *t*+1, and *I*~Eα,*t*+1~ and *I*~Eβ,*t*+1~ be the equivalent embryonic individuals. Replacing the letter *I* with *U* gives the designations for their *U*ninfected equivalents.

If we assume no paternal transmission of mitochondria (that is, offspring will always have only the mother\'s haplotype), the numbers of individuals with a given mitochondrial haplotype can be designated the same way as the number of individuals with or without *Wolbachia* infection (defined by [Equations (1)](#equ1){ref-type="disp-formula"} and [(4)](#equ4){ref-type="disp-formula"}). For example, we can replace *I*~A,t+1~ with *I*~α,t+1~ or *I*~β,t+1~ to designate the number of *I*nfected adult females with the mitochondrial haplotype *α* or *β*. Analogously, we can replace *U*~E,t+1~ with *U*~Eα,t+1~ or *U*~Eβ,t+1~ to indicate the number of *U*ninfected *E*mbryonic individuals with the mitochondrial haplotype *α* or *β* (see [Supplementary Table S3](#sup1){ref-type="supplementary-material"} for all probability combinations of offspring haplotypes).

### Generating scenarios for varying transmission parameters

We first considered the models mathematically and qualitatively to identify effects of maternal transmission leakage (*μ*\>0), incomplete CI (*H*\>0) and immigration/emigration. We then considered known cases where *Wolbachia* successfully invaded *Aedes* populations (involving *w*Mel releases) and where the infection did not establish (involving *w*MelPop releases). In these situations, most population parameters have been estimated, and we used this information to indicate expected haplotype frequencies when there is maternal transmission leakage, immigration/migration and/or incomplete CI. We did not include paternal transmission in our analyses because the phenomenon has not been clearly demonstrated in mosquitoes, but we discuss how it might influence results of the models.

We tested the power of mitochondrial variants to detect imperfect transmission events (*μ*\>0) under different levels of CI by simulating a population with different infection and haplotype frequencies. We tested two methods for detecting maternal transmission: (1) the traditional approach ([@bib44]) of field sampling of live females and their offspring before screening for *Wolbachia* infection (method 1) and (2) the alternative approach of sampling field uninfected mosquitoes for mitochondrial haplotype frequency (method 2). The models were run in R3.1 ([@bib36]).

Results
=======

Diagnostic markers for *Wolbachia* infection in *A. aegypti*
------------------------------------------------------------

We identified one SNP in the mitochondrial *COI* region that differentiates the *w*Mel- and *w*MelPop-infected haplotype from haplotypes found in uninfected field populations of *A. aegypti* ([Table 4](#tbl4){ref-type="table"}). The diagnostic SNP represents a G to A transition at the 531 bp position in the amplicon of the *COI* region. The *Wolbachia*-associated *COI* haplotype was absent from all investigated non-Australian mosquito populations ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}, see haplotype 8 in [Supplementary Table S4](#sup1){ref-type="supplementary-material"}), but was detected at low frequencies in uninfected mosquitoes from two Australian populations (8.3--13.2%). We did not find a diagnostic *COI* haplotype associated with the *w*AlbB infection

The region amplified by primer pair 4 contained a G to A transition at the 295 bp position that allowed differentiation of *w*Mel- and *w*MelPop-infected mosquitoes from most non-Australian samples ([Table 4](#tbl4){ref-type="table"}; haplotype 1 versus others, [Supplementary Table S5](#sup1){ref-type="supplementary-material"}). Complete differentiation is achieved when one of position 235, 601 or 604 is considered in the case where position 295 shares the same base with the *w*Mel- or *w*MelPop-infected mosquitoes (compare haplotypes 1 and 8 in [Supplementary Table S5](#sup1){ref-type="supplementary-material"}). The infection-associated SNP combination was detected in natural mosquito populations in Australia with frequencies ranging from 20 to 50% ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}).

In the *ND4* region we found 15 haplotypes, one of which (G→A at 210 bp) ([Table 4](#tbl4){ref-type="table"}) was fully diagnostic for the *w*AlbB infection in all investigated populations ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}, see haplotype 5 of [Supplementary Table S6](#sup1){ref-type="supplementary-material"}). Amplicon sequencing of the *ND5*, primer pair 1 and primer pair 6 regions each revealed one haplotype associated with all three *Wolbachia* infections in *A. aegypti*, but this haplotype was fully diagnostic only in the Brazilian samples ([Supplementary Figures S4--S6](#sup1){ref-type="supplementary-material"}, see [Supplementary Tables S7--S9](#sup1){ref-type="supplementary-material"} for haplotype combinations).

In summary, we found that *w*Mel and *w*MelPop could be completely differentiated from the non-Australian populations with one *COI* SNP and a combination of at least two SNPs in primer pair 4 amplicons. The *w*AlbB infection can be completely differentiated from all investigated populations with only one *ND*4 SNP ([Table 4](#tbl4){ref-type="table"}).

With ddRAD-seq we found 92 SNPs in 28 RAD loci that spanned 11 mitochondrial genes and these were present in at least 80% of individuals ([Supplementary Table S10](#sup1){ref-type="supplementary-material"}). All RAD loci were concatenated to form superhaplotypes with a final length of 2246 bp. We found 59 unique superhaplotypes in 257 individuals. Haplotype networks for the ddRAD and amplicon data sets were concordant. Out of 28 ddRAD loci, 15 covered parts of mitochondrial genes that were not analysed via amplicon sequencing (*ND2*, *COIII*, *ATP6*, *ND1* and *ND6*; [Supplementary Table S10](#sup1){ref-type="supplementary-material"}). However, we did not detect additional SNPs that would be fully diagnostic for *w*Mel infection in Australia. Even though the infection-associated superhaplotype 1 did not appear in any of the overseas samples, it was found in 12.1% of the Australian samples ([Figure 2](#fig2){ref-type="fig"}).

Nuclear copies of the mitochondrial DNA sequences (NuMts) are present in the *A. aegypti* genome ([@bib2]) and may complicate genotype assignment. However, diagnostic SNPs that were found via amplicon sequencing did not exhibit any form of heteroplasmy or ambiguous base calls. Furthermore, RAD-seq-generated SNPs that spanned 11 mitochondrial genes supported the haplotype networks generated with the single locus data. We also did not detect premature stop codons in any of the haplotypes or superhaplotypes. Therefore, it is unlikely that our haplotype analyses were confounded by NuMts.

*Wolbachia* dynamics modelling
------------------------------

We defined a set of initial conditions as follows: Haplotype *β* was at a higher frequency in infected than uninfected mosquitoes (100 vs 0--13% based on molecular data). Hence, we start with *β*~I,0~\>*β*~U,0~ (that is, *α*~I,0~\<*α*~U,0~).The site of *Wolbachia* release and the neighbouring population (population 2) had the same initial uninfected haplotype frequency, that is, *α*~U,0~(1)=*α*~U,t~(2).The viability of eggs, *δ*~*I*~ and *δ*~*U*~ is seasonally dependent, particularly for the *w*MelPop infection. In the wet season, we assumed that all eggs, regardless of infection, have the same probability of being viable. Based on the average number of rainy days in Cairns, Queensland and viability data from [@bib22], we estimated that viability would decrease to ∼0.75 in uninfected eggs. For infected eggs, we considered the same viability (no fitness difference) and viability decreasing to 0.1 (as in *w*MelPop).We assumed no difference in daily fecundity between infected and uninfected mosquitoes, *b*~*I*~=*b*~*U*~=0.3 and no seasonal dependence. The value was chosen to correspond to survival of juveniles to reproductive age with a small cost for all infection types, *s*~*I*~=0.85 versus *s*~*U*~=0.9, such that *b*~*I*~*s*~*I*~ and *b*~*U*~*s*~*U*~ correspond to the values described by [@bib42].The daily adult survival rate (*v*~*U*~) was set to 0.85, and assumed to be constant throughout both wet and dry seasons ([@bib20]). We considered two scenarios: (1) no effect of *Wolbachia* and (2) a much lower survival of 0.65 (corresponding to *w*MelPop) ([@bib49]).The juvenile development time was dependent on season, but not infection. We set the overall development time, *τ=*19 and 36 days for wet and dry season, respectively. Egg development and post-larval pre-reproductive period were *ω*=3 and 14 days and *κ*=6 and 8 days, respectively. The increase in length of each period simulates time spent in quiescence (for eggs) during the dry season and/or reduction in average temperature.Larval competition parameters were set to *a*=0.1 and *c*=0.2 to prevent the population from expanding beyond 10 000 individuals ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}).We implemented augmentative releases of 10 000 infected individuals every 7 days from the start for 12 releases.The two seasons, wet and dry season, were set to 183 days each.

We varied the maternal transmission leakage rate, *μ*, and the CI rate, 1--*H*, arbitrarily. For immigration/migration rates, we chose between an approximated value, *m*=0.03%, of the population per generation ([@bib7]), and an arbitrarily high rate, *m*=6%.

*Maternal transmission leakage* (*μ*\>0) by itself leads to decoupling of the *Wolbachia* infection status and associated mitochondrial variation, such that *Wolbachia*-associated mtDNA genetic background shows up in the uninfected fraction of the population ([Figure 3a](#fig3){ref-type="fig"} and [Supplementary Text 1](#sup1){ref-type="supplementary-material"}). If persisting indefinitely, the haplotype frequencies in uninfected mosquitoes will eventually become the same as those in infected mosquitoes in the population.*Paternal transmission of Wolbachia* (*ξ*\>0) leads to the same result but working in the opposite direction: it causes haplotype frequencies in infected individuals to become the same as those in the uninfected mosquitoes of the population. The effects of both transmission parameters are limited by fitness of the infected/uninfected individuals (fecundity, *b*~I~ and *b*~U~; egg survival, *δ*~I~ and *δ*~U~; non-egg juvenile survival, *s*~I~ and *s*~U~) and strength of CI (1--*H*) ([Supplementary Text 1](#sup1){ref-type="supplementary-material"}).*Immigration/emigration* allows for two (or more) interacting populations to equilibrate their haplotype frequencies. As a result, these processes potentially reduce or reverse the effect of maternal transmission leakage on haplotype frequency in uninfected individuals ([Figure 3b](#fig3){ref-type="fig"} and [Supplementary Text 1](#sup1){ref-type="supplementary-material"}).*Cytoplasmic incompatibility* does not affect haplotype frequency directly when there is no transmission leakage (*μ*=0 and *ξ*=0). However, in the presence of leakage, the magnitude of CI could limit the effects of leakage on haplotype frequencies when immigration is present ([Figure 3c](#fig3){ref-type="fig"} and [Supplementary Text 1](#sup1){ref-type="supplementary-material"}). For example, high levels of CI (*H* close to zero) reduce the effect of maternal transmission leakage at high infection frequencies (*p*~t~ close to 1). As most mating pairs will be with infected males, any transmission leakage will be suppressed by CI, ultimately leaving only uninfected migrants if immigration occurs, or no uninfected individuals if immigration is absent. High levels of CI also completely suppress the effect of paternal transmission of *Wolbachia* on haplotype frequencies in uninfected and infected individuals. However, when CI levels become too low (for example, *H*=0.7), *Wolbachia* invasion will drastically slow down, reducing the effect of transmission leakage ([Figure 3c](#fig3){ref-type="fig"}, see *H*=0.7).

### Inferences from successful *Wolbachia* invasions

Successful *Wolbachia* invasions result in a stable frequency of *Wolbachia* infection in a population. Invasions of *w*Mel in *A. aegypti* populations from Australia have led to stable infections at a frequency close to 1 ([@bib14]). Here, we based fitness parameters on estimates obtained for the *w*Mel infection in *A. aegypti*.

First, if an infection goes to fixation (*p*~t~=1), it can easily be inferred that immigration is absent, and that maternal transmission of infection is perfect (*μ*=0) and/or cytoplasmic incompatibility is complete (*H*=0) ([Supplementary Text 2](#sup1){ref-type="supplementary-material"}). Hence, any maternal transmission leakage can only be detected from haplotype frequencies during the invasion phase, that is, when uninfected individuals are still present.

Persistence of uninfected individuals in a stable infection implies that there is (1) immigration of uninfected mosquitoes into the invasion site (*m*\>0); and/or (2) imperfect maternal transmission of *Wolbachia* (*μ*\>0) and incomplete CI (*H*\>0) as explained previously ([Supplementary Text 2](#sup1){ref-type="supplementary-material"}). Uninfected individuals have persisted in *A. aegypti* populations that were invaded by *Wolbachia* ([@bib14]).

After invasion, if (1) the frequency of the infection-associated haplotype *β* significantly increases in uninfected individuals and is moving towards the value present in infected individuals, we can infer that maternal transmission leakage and incomplete CI are likely to be present ([Figure 4a](#fig4){ref-type="fig"}). Under this scenario, however, the presence of immigration cannot be inferred. On the other hand, if (2) haplotype *β* in uninfected individuals is at a higher frequency during the invasion phase than after invasion, it is likely that immigration coupled with almost complete CI (*H*≈0) have countered the effects of transmission leakage ([Figure 4b](#fig4){ref-type="fig"}). (3) If no significant difference in haplotype frequencies is observed throughout the invasion and post-invasion periods, maternal transmission is probably perfect (*μ*=0) and immigration is present (*m*\>0), allowing uninfected individuals to persist. Under such a scenario we cannot make any inferences about CI.

### Inferences from failed *Wolbachia* invasions

Here, we approximated fitness parameters based on known releases of *w*MelPop infections that failed to invade an *A. aegypti* population ([@bib49]). When the infection fails to persist at high frequency, it is difficult to infer levels of CI and low/moderate levels of migration in the presence of maternal transmission leakage based on uninfected haplotype frequency (compare [Figures 4c and d](#fig4){ref-type="fig"}). Maternal transmission leakage will transform the haplotype frequencies of uninfected individuals as long as the infection is still present in the population. This change in haplotype frequency could still be detected even after the infection has been lost ([Figure 4c](#fig4){ref-type="fig"}). Thus, in this scenario, we would suggest first screening after releases are terminated as it would be redundant to screen samples during invasion to detect maternal transmission leakage. If the absence of maternal transmission leakage (*μ*=0) is suspected, individuals from invasion period could then be screened to test for a lack of change in uninfected haplotype frequency.

Workflow to detect maternal transmission leakage of *Wolbachia*
---------------------------------------------------------------

We provide a workflow that guides inferences about the processes underlying *Wolbachia* dynamics in host populations based on the analyses of infection and haplotype frequencies ([Figure 5](#fig5){ref-type="fig"}). The analyses are split into two sampling points: during the release phase and after releases (successful invasion or loss of infection). We also assess the power to detect maternal transmission leakage at these two sampling time points using the uninfected haplotype frequencies (method 2). We compare our method with the traditional approach ([@bib44]) that assumes field sampling of infected gravid females to directly assess infection transmission to offspring (method 1).

First, analyses of mitochondrial haplotype distributions enable detection of the presence or absence of maternal transmission leakage for both sampling regimes (during and after the *Wolbachia* invasion). Sampling during the invasion phase is most informative when the infection frequency lies between 0.5 and 0.8. If the infection frequency (*p*~*t*~) is too high, CI can hinder transmission leakage, and if *p*~*t*~ is too low, there are too few transmission leakage events to be detected.

For post-release sampling, samples can be collected when the infection frequency has stabilised or when it drops to zero. For the traditional method 1, we simulated the situation where 100 and 200 offspring are obtained from the field-caught infected females. For method 2, we simulated the situation where mosquitoes are sampled over 5 weeks (assuming a trapping rate of 0.5% of the population per week) and leakage was detected through the presence of an uninfected individual with an infection-associated haplotype (*β*). The screening protocols were simulated 100 000 times, assuming a low rate of immigration/emigration at a rate of *m*=0.3% of the population per generation corresponding to a relatively isolated population (cf, [@bib14]).

With method 1, the ability to detect transmission leakage increases with leakage levels, but not with changing CI levels. This method is useful during and after an invasion, but cannot be used once an infection is lost. With method 2, relevant data on leakage can be obtained under all scenarios and the detection rate depends not only on the maternal transmission rate, but also on CI ([Table 5](#tbl5){ref-type="table"}). The two methods have comparable power in a situation where CI is not strong.

Case study
----------

To highlight the utility of our approach, we considered the case of the *Wolbachia* infection *w*Ri and its recent invasion and spread through the populations of *D. simulans* in eastern Australia ([@bib25]). The infection was initially detected in California ([@bib19]) where it was tightly associated with a particular mtDNA variant ([@bib10]) that then spread in populations alongside the *Wolbachia* infection ([@bib45]). Based on the data presented by [@bib25], before the arrival of *w*Ri infection to Australia, there was one haplotype (haplotype A) present in eastern Australian populations. This haplotype was present in both uninfected individuals and individuals carrying the *w*Au infection that is not invasive through cytoplasmic incompatibility. In 2004, in New South Wales, Australia, before *w*Ri invading, New South Wales populations had a *w*Au frequency of 48.7%. By 2008, 7 sites had a new *w*Ri infection with a frequency of 7.4±4.7% *w*Au infection was present with a frequency of 56.1% and uninfected individuals comprised 36.4% of the total sample. Moreover, mitochondrial haplotype R was now detected for the first time and had a frequency of 14.8±14.8%, higher than the frequency of *w*Ri because it was also detected in some uninfected individuals. By 2011, the frequency of *w*Ri had increased to 91.4±3.5% and *w*Au was no longer detected. Moreover, both infected and uninfected individuals had haplotype R, consistent with patterns in other populations outside Australia ([@bib45]).

Applying the approach developed in the present study ([Figure 5](#fig5){ref-type="fig"}), the documented *w*Ri invasion in Australia can be used to identify signatures of imperfect transmission and other processes. This is possible because the *D. simulans* population was sampled before invasion of *w*Ri and the infection source population was known to be carrying a particular mtDNA variant. Based on [Figure 5](#fig5){ref-type="fig"} (assuming we have no knowledge of laboratory estimates), it can be surmised that: The increase in frequency of haplotype R (the invading haplotype) in uninfected individuals immediately implicates maternal transmission leakage. This haplotype was not previously detected in any Australian population. If migration was involved, we would have expected uninfected individuals to carry haplotype A.Given that transmission leakage is present, we can infer incomplete CI because haplotype R has increased in frequency in uninfected individuals in New South Wales over time even when infection has reached high frequencies, instead of increasing initially and then dropping as the infection approaches high frequencies as expected under complete CI.There is no evidence for a high incidence of paternal transmission because no *w*Ri-infected flies with haplotype A were detected. However, it would be difficult to detect a low rate of paternal transmission unless very large sample sizes were available from the invasion period.

Discussion
==========

We discovered mtDNA variants associated with the *w*Mel and *w*MelPop *Wolbachia* infections that allow complete differentiation of *A*. *aegypti* from the release stock and the wild samples collected in Brazil, Indonesia and Vietnam. These mtDNA markers, however, are not fully diagnostic in Australian populations. High similarity between the infected colonies and the Australian populations is not surprising given that all infected samples originate from a single isofemale line which has the Australian genetic background ([@bib30]; [@bib31]; [@bib47]). We also detected a single diagnostic SNP that distinguishes the *w*AlbB infection from other *Wolbachia* strains and field samples of *A. aegypti*. The *w*AlbB was generated by the *Wolbachia* transfer from *A. albopictus* into the Waco *A. aegypti* strain that originated from Texas ([@bib48]). The diagnostic markers we discovered can now be used to generate a high-throughput SNP genotyping assay that could be run in parallel with the detection of the *Wolbachia* infection ([@bib27]). Such an assay would assist in ensuring successful *Wolbachia* invasions into the *A. aegypti* populations around the world in an effort to supress dengue transmission.

Our modelling results highlight the extent to which the presence of maternal leakage leads to increased numbers of uninfected mosquitoes with the mtDNA haplotype associated with the infection (that is, haplotype *β*). The usual method for studying maternal transmission of *Wolbachia* in the field involves directly testing the *Wolbachia* infection status in the offspring of field-caught females that are infected ([@bib12], [@bib13]). Although this approach can provide an estimate of transmission leakage, the major limitation is the substantial number of individuals that need to be tested. This is because useful information is obtained only from offspring of captured females that are infected. The mtDNA-based approach has several practical advantages in that live, field females are not required, and that the data can capture the average effects of leakage across time rather than only at the point when screening is undertaken. Although it might be less powerful when detecting low rates of maternal transmission leakage (*μ\<*0.05) during the invasion phase, the mtDNA-based approach performs well after the release phase, particularly when there is no invasion or when some offspring hatch in incompatible crosses.

Based on the modelled power of detection, we propose that monitoring of mtDNA haplotype frequency in uninfected mosquitoes is a useful approach in understanding whether a failed or incomplete invasion is a result of maternal transmission leakage of *Wolbachia*. Nevertheless, estimating the maternal transmission leakage rate, *μ*, with this approach is not straightforward because of the number of variables that might affect such estimates. This is likely to require sampling of haplotypes from at least two time points.

Mitochondrial variation can also help in understanding the impact of other population processes such as migration patterns. Detection of immigrants is straightforward when high infection frequencies have been achieved. If we assume strong CI (*H* almost 0) or negligible paternal transmission of mitochondria, changes in the frequency of the haplotype associated with the infection in uninfected individuals after invasion provides a signature of immigration. Migration rates would still need to be directly estimated with approaches such as mark-release-recapture (see, for example, [@bib29]) and population genetic studies (cf, [@bib7]; [@bib8]; [@bib37]).

Monitoring of mitochondrial haplotype dynamics alone is not sufficient for inferring CI, but when coupled with maternal transmission of *Wolbachia* and other parameters, especially in the event of a successful invasion, it allows for the strength of CI to be inferred. We found that detecting maternal leakage of *Wolbachia* transmission via mtDNA haplotypes was affected by the strength of CI, and strong CI would have prevented any genetic material from the infected individuals leaking into the uninfected population via paternal transmission (cf, [@bib18]). Strong CI allows re-establishment of the original haplotype frequency among uninfected individuals through immigration, as CI ensures the elimination of pre-existing uninfected individuals. However, the exact CI rate can only be inferred through observing hatch rate in gravid uninfected females captured during the release of infected mosquitoes.

In conclusion, we found sufficient differentiation between uninfected and infected haplotypes to allow qualitative detection of population parameters from mtDNA data during and after releases of *Wolbachia*-infected mosquitoes. Based on the scenarios presented, monitoring of haplotype frequencies in uninfected individuals should provide information on maternal transmission and the presence of immigrants in invaded populations. Our models could be applied not only to mosquito releases, but to any *Wolbachia* release program or temporal study of *Wolbachia* dynamics in natural populations, as long as there is mtDNA variation that differentiates infected and uninfected populations.
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![Diagrams depicting individuals with associated mitochondrial haplotypes and *Wolbachia* infection status that would be sampled from the release site under: (**a**) complete CI and perfect maternal transmission of *Wolbachia* (null model); (**b**) imperfect maternal transmission of *Wolbachia* but complete CI. Incomplete CI would also lead to some uninfected offspring in the infected male × uninfected female cross; (**c**) immigration of uninfected individuals, assuming the immigrating mosquitoes are similar to the uninfected individuals, hence differentiated from the infected individuals; (**d**) paternal transmission of mitochondria (D1) or *Wolbachia* (D2). For (D1), if CI is incomplete, there will be presence of uninfected offspring that are heteroplasmic, and for (D2) if CI is complete, the profile will be identical to (**a**). Heteroplasmic individuals can either produce heteroplasmic gametes or randomly pass on only one haplotype.](hdy201597f1){#fig1}

![Network of RAD-seq superhaplotypes. Each nonsolid black coloured circle represents observed haplotype with greater circle size indicating greater number of individuals with that haplotype. Solid black circles represent a single base change and the interrupted line with numbers represents a larger number of base differences. Haplotype with number 1 is the haplotype associated with the *w*Mel infection.](hdy201597f2){#fig2}

![Frequency of haplotype *β* (infection-associated haplotype) in uninfecteds vs time in a modelled release. Unless stated, *μ*=0.1, *m*=0.0003, *H*=0.1. (**a**) Comparison of different magnitude of maternal transmission leakage, *μ*=0, 0.0001, 0.001, 0.01 and 0.1. (**b**) Comparison of different magnitude of immigration rates, *m*=0. (**c**) Comparison of variable levels of incomplete CI in the presence of transmission leakage, *μ*\>0, and immigration, *m*\>0 (*H*=0, 0.01, 0.1, 0.5, 0.7).](hdy201597f3){#fig3}

![Plot of infection-associated haplotype frequency in uninfected: *β*, *β*~U,*t*~, infection frequency, *p*~*t*~ and population size (shaded area). (**a**) Successful invasion with *μ*=0.05, *m*=0.0003, *H*=0.1 (incomplete CI). (**b**) Successful invasion with *μ*=0.05, *m*=0.0003 with incomplete CI, *H*=0. (**c**) Failed invasion with *μ*=0.05, *m*=0.0003. (**d**) Release that fails to establish with *μ*=0.05, *m*=0.06.](hdy201597f4){#fig4}

![List of possible observations (O), their respective inferences on model parameters (I) and sampling strategy to make further inferences on model parameters (S) based on three possible *Wolbachia*-invasion outcomes: (1) fixed at 100% (2) stable coexistence of *Wolbachia-*infected and uninfected; and (3) infection extinction. We were interested in identifying whether certain parameters, particularly the maternal transmission leakage rate (*μ*), incompatible hatch rate (*H*) and immigration rate (*m*), differed from 0 based on observations of infection-associated haplotype frequencies at some time, *t*, in uninfected, *β*~U,*t*~ and infected, *β*~I,*t*~ individuals. *β*~U,0~ and *β*~I,0~ specify frequencies at time *t*=0, before introduction of *Wolbachia*-infected individuals. For scenarios where parameters are listed as '≥0\' or not mentioned, inference was not possible. We also included inferences on paternal transmission of *Wolbachia* rate (*ξ*), but this only applies when there is negligible paternal transmission of mitochondria. Stable infection frequency is denoted by *p*~*t*~=*p*~*t+k*~.](hdy201597f5){#fig5}

###### Details of samples processed

                                         *Number sequenced for each marker*                                       
  ------------ ------------ ------------ ------------------------------------ ----- ----- ----- ----- ----- ----- -----
  *w*Mel        Laboratory      2010     29                                   29                                   
                Gv and YK    2011, 2012  12                                   12    10    5     5     5     5     5
  *w*MelPop     Laboratory      2009     23                                   23                                   
                    MB          2012     10                                   10    10    5     5     5     5     5
  *w*AlbB       Laboratory      2014     10                                   10    10    10    10    10    10    10
  Uninfected        Gv       2010, 2011  85                                   79    79    78    78    79    78    75
                    YK          2011     27                                   24    24    23    27    23    23    22
                   Indo         2011     30                                   30    30    27    30    30    30    26
                   Viet         2011     50                                   30    30    11    26    30    30    11
                    Br          2012     38                                   30    30    33    33    31    32    30
  TOTAL                                  314                                  277   223   192   214   213   213   184

Abbreviations: BR, Rio de Janeiro, Brazil; Gv, Gordonvale, QLD, Australia; Indo, Yogyakarta, Indonesia; *n*, number of individuals screened for at least one of the markers; Viet, Trí Nguyên Island, Vietnam; YK, Yorkeys Knob, QLD, Australia.

###### Equation symbols (adapted from [@bib42])

  *Symbol*                     *Definition*
  ---------------------------- -----------------------------------------------------------------------------------------------------------------------
  *b*~I~(*b*~U~)               Number of female embryos produced by an I (U) female per day
  *H*                          Hatch rate of incompatible crosses (that is, infected sperm with uninfected egg)
  I~A*,t*~(1)                  Number of I reproductive females at time *t* in population 1; I~A*,t*~(1)= I~α*,t*~(1)+I~β*,t*~(1)
  U~A*,t*~(1)                  Number of U reproductive females at time *t* at population 1; U~A*,t*~(1)=U~α*,t*~(1)+U~β*,t*~(1)
  I~E*,t*~ (U~E*,t*~)          Number of newly produced I (U) female embryos at time *t*
  I~α*,t*~(I~β*,t*~)           Number of I reproductive females with α (β) mitochondrial background
  U~α*,t*~(U~β*,t*~)           Number of U reproductive females with α (β) mitochondrial background at time *t*
  *p*~*t*~                     Frequency of reproductive I females at time *t*, I~A*,t*~/(I~A*,t*~+U~A*,t*~)
  *α*~*I*,*t*~(*β*~*I*,*t*~)   Frequency of α (β) background in reproductive I females at time *t*, that is, I~α*,t*~/I~A*,t*~ and I~β*,t*~/I~A*,t*~
  *α*~*U*,*t*~(*β*~*U*,*t*~)   Frequency of α (β) background in reproductive U females at time *t*, that is, U~α*,t*~/U~A*,t*~ and U~β*,t*~/U~A*,t*~
  *s*~I~(*s*~U~)               Probability of I juvenile (U juvenile) post egg stage becoming a reproductive adult (irrespective of CI)
  *δ*~I~(*δ*~U~)               Probability of I (U) eggs surviving to larval stage
  τ~I~(τ~U~)                   Average length of the pre-reproductive period for I (U); reproduction begins at τ~I~+1 (τ~U~+1)
  *v*~I~(*v*~U~)               Daily survival rate of I (U) reproductive adults
  *μ*                          Probability of an infected female producing uninfected offspring (maternal leakage)
  *ξ*                          Probability of paternal transmission of *Wolbachia*
  *m*                          Emigration/immigration rate of mosquitoes between two populations per generation
  *a, c*                       Parameters for larval density-dependent mortality
  *ω*                          Length (in days) of pre-reproductive period spent as egg
  *κ*                          Length (in days) of pre-reproductive period spent as pupae and pre-reproductive adult
  *b*~I~(*b*~U~)               Number of female embryos produced by an Infected, I (Uninfected, U) female per day
  *H*                          Hatch rate of incompatible crosses (that is, infected male cross with uninfected female)

Abbreviations: I, infected; U, uninfected.

###### Punnett square of the uninfected/infected cross and probabilities of uninfected/infected egg

  *Parents*                       *Uninfected female, U*~*A,t*~                                                                    *Infected female, I*~*A,t*~
  ------------------------------- ------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Uninfected male (1--*p*~*t*~)   *U*: 1                                                                                           *U*: infection fails to transfer maternally; probability *μ*
                                  *I*: 0                                                                                           *I*: infection transmitted maternally; probability 1--*μ*
  Infected male (*p*~*t*~)        *U*: viable embryo produced and no paternal transmission of infection; probability=(1--*ξ*)*H*   *U*: infection fails to transmit maternally, viable embryo produced and no paternal transmission; probability *μ* (1--*ξ*)*H*
                                  *I*: viable embryo produced and paternal transmission of infection occurs; probability=*ξH*      *I*: Infection transmitted maternally; probability 1--*μ* OR failed transmission, viable embryo produced and paternal transmission of infection; probability *μξH*

The Punnett square displays the number of uninfected and infected reproductive females (top row), and probability of encountering each infected/uninfected male. The resulting cells display the probability of uninfected (U) and infected (I) eggs GIVEN the cross. To obtain the number of offspring each day, we multiply the values: row header value × column header value × cell values × daily fecundity of infected (uninfected) reproductive female, *b*~*I*~ (*b*~*U*~).

###### Amplicon regions with the most informative SNPs and their characteristics for *Wolbachia* infections (*w*Mel, *w*MelPop and *w*AlbB) in field-caught *Aedes aegypti* from Australia, Indonesia, Vietnam and Brazil

  *Region*    *Diagnostic*   *SNP (position)*   *Location*                   *wMel*                                    *wMelPop*                     *wAlbB*
  ---------- -------------- ------------------ ------------ ----------------------------------------- -------------------------------------------- ------------
  *COI*           G→A            (531 bp)       Australia    *COI* [a](#t4-fn3){ref-type="fn"} (87%)    *COI* [a](#t4-fn3){ref-type="fn"} (87%)       *ND4*
  *ND5*           T→C            (352 bp)       Indonesia                     *COI*                                 *COI*, primer 4                   *ND*4
  *ND4*           G→A            (210 bp)        Vietnam                      *COI*                    *COI*, primer 4[b](#t4-fn4){ref-type="fn"}     *ND4*
  Primer 4        G→A            (295 bp)         Brazil                  *COI*, *ND5*                           *COI*, primer 4, *ND*5             *ND4, ND5*

Abbreviation: SNP, single-nucleotide polymorphism.

Diagnostic SNP type (for example, G→A designates G to A transition) and bp position within the amplicon

*COI* marker for wMel/wMelPop infection is 87% informative in Australian samples.

Primer pair 4 requires consideration of at least one more SNP in addition to the SNP at 295 bp to fully differentiate samples from Vietnam.

###### Qualitative rate of detection of maternal transmission leakage of *Wolbachia*

                                         *During invasion phase*   *Post invasion (successful)*[a](#t5-fn2){ref-type="fn"}   *Post release (noninvasion)*                                                            
  ------------------------------------- ------------------------- --------------------------------------------------------- ------------------------------ ------- ------- ------- ------- ------- ---- ---- ------- -------
  Screened[c](#t5-fn4){ref-type="fn"}              100                                       200                                         100                 200     100     200     100     200    NA   NA    100     200
  *μ*=0.05, *H*=0.5                               0.994                                     0.999                                       0.989               0.999   0.994   0.999   0.998   0.999   0    0    1.000   1.000
  *μ*=0.05, *H*=0.1                               0.994                                     0.999                                       0.681               0.899   0.994   0.999   0.479   0.500   0    0    1.000   1.000
  *μ*=0.05, *H*=0                                 0.994                                     0.999                                       0.601               0.843   0.994   0.999    \~0     \~0    0    0    1.000   1.000
  *μ*=0.01, *H*=0.5                               0.633                                     0.867                                       0.582               0.825   0.633   0.867   0.687   0.783   0    0    0.957   0.969
  *μ*=0.01, *H*=0.1                               0.633                                     0.867                                       0.199               0.359   0.633   0.867   0.117   0.150   0    0    0.976   0.976
  *μ*=0.01, *H*=0                                 0.633                                     0.867                                       0.164               0.302   0.633   0.867    \~0     \~0    0    0    0.969   0.969
  *μ*=0                                             0                                         0                                           0                   0       0       0       0       0     0    0      0       0

Abbreviation: NA, not available.

Successful post invasion implies infection persisting and/or reaching high infection frequencies. Otherwise the infection fails to establish.

Method 1 involves sampling females and rearing them to obtain offspring. Females are then screened for *Wolbachia* and their offspring subsequently screened. The probabilities reported here are based on 100 000 simulated sampled females; only infected females are included in estimating the rate of imperfect transmission. Method 2 involves sampling and screening field individuals for infection. Those that are uninfected are screened for haplotype *β* (the haplotype not initially found in uninfected individuals). A total of 100 000 individuals were simulated and the proportion of replicates that had haplotype *β* at a frequency \>0 are given.

The number of infection offspring screened (method 1) or the number of uninfected individuals screened (method 2). The actual number of individuals screened in method 1 is far greater than under method 2 as the female parents are caught from the field and reared to obtain offspring before only retaining offspring of infected females. The actual number to screen for method 2 depends on the frequency of uninfected individuals.
